Antiretroviral Treatment in Pregnancy
Cross-source consensus on Antiretroviral Treatment in Pregnancy from 1 sources and 6 claims.
1 sources · 6 claims
How it works
Benefits
Dosage & preparation
Evidence quality
Highlighted claims
- Achieving 95% or higher antiretroviral treatment coverage among pregnant women with HIV is a WHO MTCT elimination criterion. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Antiretroviral treatment coverage for pregnant women with HIV must reach 95% or higher to meet WHO MTCT elimination criteria. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Antiretroviral treatment coverage among pregnant women with HIV must be 95% or higher to meet WHO MTCT elimination criteria. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- ART coverage for pregnant women with HIV is one of the five programmatic pillars the WHO requires for MTCT elimination validation. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Achieving at least 95% antiretroviral treatment coverage among pregnant women with HIV is a required criterion for WHO MTCT elimination validation. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Brazil met the 95% or higher ART coverage target for pregnant women with HIV as part of its validated elimination program. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Brazil achieved at least 95% antiretroviral treatment coverage among pregnant women with HIV as part of its elimination program. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems